Relmada Therapeutics, Inc. (RLMD)
NASDAQ: RLMD · Real-Time Price · USD
4.240
+0.240 (6.00%)
At close: Dec 5, 2025, 4:00 PM EST
4.220
-0.020 (-0.47%)
After-hours: Dec 5, 2025, 7:29 PM EST
Relmada Therapeutics Market Cap
Relmada Therapeutics has a market cap or net worth of $310.93 million as of December 5, 2025. Its market cap has increased by 245.87% in one year.
Market Cap
310.93M
Enterprise Value
297.05M
1-Year Change
245.87%
Ranking
Category
Stock Price
$4.24
Market Cap Chart
Since September 30, 2015, Relmada Therapeutics's market cap has increased from $56.60M to $310.93M, an increase of 449.35%. That is a compound annual growth rate of 18.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 310.90M | 1,880.25% |
| Dec 31, 2024 | 15.70M | -87.40% |
| Dec 29, 2023 | 124.60M | 18.67% |
| Dec 30, 2022 | 105.00M | -73.42% |
| Dec 31, 2021 | 395.00M | -24.17% |
| Dec 31, 2020 | 520.90M | 30.00% |
| Dec 31, 2019 | 400.70M | 1,125.38% |
| Dec 31, 2018 | 32.70M | 247.87% |
| Dec 29, 2017 | 9.40M | -28.24% |
| Dec 30, 2016 | 13.10M | -54.67% |
| Dec 31, 2015 | 28.90M | -48.94% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 907.67B |
| Johnson & Johnson | 486.80B |
| AbbVie | 403.07B |
| UnitedHealth Group | 300.19B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 251.40B |
| Abbott Laboratories | 216.52B |